Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12784573 | 0.94 | — | — | |
| SCHEMBL8245227 | 0.94 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL8247848 | 0.92 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13059684 | 0.92 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL11976324 | 0.92 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13059689 | 0.92 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL11976323 | 0.92 | ADRB3 (0.35) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13711314 | 0.90 | CTSB (0.38) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13711327 | 0.89 | ADRB3 (0.33) | CYP3A4ADRB3ADRA2BADRA2C | |
| SCHEMBL13711289 | 0.88 | CYP3A4 (0.33) | CYP3A4ADRB3ADRA2BADRA2CCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2305695-A2 | Macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2103623-A2 | Novel macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2009-09-23 | — | — | EP | disclosed |